{"product_id":"global-contract-development-manufacturing-organization-cdmo-market-insights-forecast-with-potential-impact-of-covid-19-2023-2027","title":"Global Contract Development \u0026 Manufacturing Organization (CDMO) Market: Insights \u0026 Forecast with Potential Impact of COVID-19 (2023-2027)","description":"\u003cp\u003eGlobal Contract Development \u0026amp; Manufacturing Organization (CDMO) Market: Insights \u0026amp; Forecast with Potential Impact of COVID-19 (2023-2027)\u003cbr\u003e\nThe global CDMO market is estimated to reach US$269.54 billion in 2027, growing at a CAGR of 9.32%, for the period spanning 2023-2027. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R\u0026amp;D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market. However, growth of the industry will be challenged by stringent government regulations. A few notable trends include increasing demand for highly potent API manufacturing services, growing demand for quality by design services, growth in oncology segment, growing demand for process development CDMO services and lengthy and costly drug development process.\u003c\/p\u003e\n\n\u003cp\u003eIn terms of services, the global API drug market accounted for the highest share of the market and is expected to grow in future owing to growing number of biologics APIs in pipeline stage and growing adoption of multiple of therapies. Whereas on the basis of product, small molecule drugs held a major share of the market owing to the surge in the pharmaceutical R\u0026amp;D activities worldwide.\u003cbr\u003e\n \u003cbr\u003e\nIn terms of geographical areas, North America is the major contributor to the global CDMO market supported by growing collaborations and wide range of services provided by CDMOs. Asia Pacific is the fastest growing market for CDMOs owing to highly skilled workforce and low research and development cost advantage.\u003c\/p\u003e \n\n\u003cp\u003eScope of the report:\u003c\/p\u003e\n\n\u003cp\u003eThe report provides a comprehensive analysis of the global CDMO industry.\u003c\/p\u003e\n\n\u003cp\u003eThe major regional markets (North America, Europe, Asia-Pacific, Latin America and Middle East \u0026amp; Africa) have been analyzed.\u003c\/p\u003e\n\n\u003cp\u003eThe market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.\u003c\/p\u003e \n\n\u003cp\u003eThe company profiles of leading players (Catalent, Inc., Recipharm AB, Evotec SE, Lonza Group AG, Biomerieux SA and Thermo Fisher Scientific Inc.) are also presented in detail.\u003c\/p\u003e\n\n\u003cp\u003eKey Target Audience:\u003c\/p\u003e\n\n\u003cp\u003eContract Manufacturing Organization\u003c\/p\u003e\n\n\u003cp\u003ePharmaceutical Companies\u003c\/p\u003e\n\n\u003cp\u003eConsulting Firms\u003c\/p\u003e \n\n\u003cp\u003eInvestment Banks\u003c\/p\u003e\n\n\u003cp\u003eGovernment Bodies \u0026amp; Regulating Authorities\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 66 Pages \/ MCW16231460","offer_id":47647317885234,"sku":null,"price":1500.0,"currency_code":"USD","in_stock":true},{"title":"July, 2023 \/ 66 Pages \/ MCW16231461","offer_id":47647317918002,"sku":null,"price":1500.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-contract-development-manufacturing-organization-cdmo-market-insights-forecast-with-potential-impact-of-covid-19-2023-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}